Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

Contact and encirclement of glioma cells in vitro is an intrinsic behavior of a clonal human neural stem cell line.

Khosh N, Brown CE, Aboody KS, Barish ME.

PLoS One. 2012;7(12):e51859. doi: 10.1371/journal.pone.0051859. Epub 2012 Dec 11.

2.

Neural stem cell tropism to glioma: critical role of tumor hypoxia.

Zhao D, Najbauer J, Garcia E, Metz MZ, Gutova M, Glackin CA, Kim SU, Aboody KS.

Mol Cancer Res. 2008 Dec;6(12):1819-29. doi: 10.1158/1541-7786.MCR-08-0146.

3.

Double suicide gene therapy using human neural stem cells against glioblastoma: double safety measures.

Lee JY, Lee DH, Kim HA, Choi SA, Lee HJ, Park CK, Phi JH, Wang KC, Kim SU, Kim SK.

J Neurooncol. 2014 Jan;116(1):49-57. doi: 10.1007/s11060-013-1264-6. Epub 2013 Oct 11.

PMID:
24113876
4.

Targeting rat brainstem glioma using human neural stem cells and human mesenchymal stem cells.

Lee DH, Ahn Y, Kim SU, Wang KC, Cho BK, Phi JH, Park IH, Black PM, Carroll RS, Lee J, Kim SK.

Clin Cancer Res. 2009 Aug 1;15(15):4925-34. doi: 10.1158/1078-0432.CCR-08-3076. Epub 2009 Jul 28. Erratum in: Clin Cancer Res. 2010 Nov 1;16(21):5367.

5.

A preclinical evaluation of neural stem cell-based cell carrier for targeted antiglioma oncolytic virotherapy.

Ahmed AU, Thaci B, Tobias AL, Auffinger B, Zhang L, Cheng Y, Kim CK, Yunis C, Han Y, Alexiades NG, Fan X, Aboody KS, Lesniak MS.

J Natl Cancer Inst. 2013 Jul 3;105(13):968-77. doi: 10.1093/jnci/djt141.

6.

Human neural stem cells target experimental intracranial medulloblastoma and deliver a therapeutic gene leading to tumor regression.

Kim SK, Kim SU, Park IH, Bang JH, Aboody KS, Wang KC, Cho BK, Kim M, Menon LG, Black PM, Carroll RS.

Clin Cancer Res. 2006 Sep 15;12(18):5550-6.

7.

Neural stem cell-mediated enzyme/prodrug therapy for glioma: preclinical studies.

Aboody KS, Najbauer J, Metz MZ, D'Apuzzo M, Gutova M, Annala AJ, Synold TW, Couture LA, Blanchard S, Moats RA, Garcia E, Aramburo S, Valenzuela VV, Frank RT, Barish ME, Brown CE, Kim SU, Badie B, Portnow J.

Sci Transl Med. 2013 May 8;5(184):184ra59. doi: 10.1126/scitranslmed.3005365.

8.

Selective antitumor effect of neural stem cells expressing cytosine deaminase and interferon-beta against ductal breast cancer cells in cellular and xenograft models.

Yi BR, Hwang KA, Aboody KS, Jeung EB, Kim SU, Choi KC.

Stem Cell Res. 2014 Jan;12(1):36-48. doi: 10.1016/j.scr.2013.09.010. Epub 2013 Oct 1.

9.

Stereological analysis on migration of human neural stem cells in the brain of rats bearing glioma.

Kim JH, Lee JE, Kim SU, Cho KG.

Neurosurgery. 2010 Feb;66(2):333-42; discussion 342. doi: 10.1227/01.NEU.0000363720.07070.A8.

PMID:
20087133
10.

Neural stem cell-mediated delivery of irinotecan-activating carboxylesterases to glioma: implications for clinical use.

Metz MZ, Gutova M, Lacey SF, Abramyants Y, Vo T, Gilchrist M, Tirughana R, Ghoda LY, Barish ME, Brown CE, Najbauer J, Potter PM, Portnow J, Synold TW, Aboody KS.

Stem Cells Transl Med. 2013 Dec;2(12):983-92. doi: 10.5966/sctm.2012-0177. Epub 2013 Oct 28.

11.

Overexpression of Bcl-XL in human neural stem cells promotes graft survival and functional recovery following transplantation in spinal cord injury.

Lee SI, Kim BG, Hwang DH, Kim HM, Kim SU.

J Neurosci Res. 2009 Nov 1;87(14):3186-97. doi: 10.1002/jnr.22149.

PMID:
19530162
12.

PEX-producing human neural stem cells inhibit tumor growth in a mouse glioma model.

Kim SK, Cargioli TG, Machluf M, Yang W, Sun Y, Al-Hashem R, Kim SU, Black PM, Carroll RS.

Clin Cancer Res. 2005 Aug 15;11(16):5965-70.

13.

Novel method for visualizing and modeling the spatial distribution of neural stem cells within intracranial glioma.

Lin D, Najbauer J, Salvaterra PM, Mamelak AN, Barish ME, Garcia E, Metz MZ, Kendall SE, Bowers M, Kateb B, Kim SU, Johnson M, Aboody KS.

Neuroimage. 2007;37 Suppl 1:S18-26. Epub 2007 May 13.

PMID:
17560798
14.

MMP14 as a novel downstream target of VEGFR2 in migratory glioma-tropic neural stem cells.

Alexiades NG, Auffinger B, Kim CK, Hasan T, Lee G, Deheeger M, Tobias AL, Kim J, Balyasnikova I, Lesniak MS, Aboody K, Ahmed AU.

Stem Cell Res. 2015 Nov;15(3):598-607. doi: 10.1016/j.scr.2015.10.005. Epub 2015 Oct 22.

15.

Pharmacokinetic study of neural stem cell-based cell carrier for oncolytic virotherapy: targeted delivery of the therapeutic payload in an orthotopic brain tumor model.

Thaci B, Ahmed AU, Ulasov IV, Tobias AL, Han Y, Aboody KS, Lesniak MS.

Cancer Gene Ther. 2012 Jun;19(6):431-42. doi: 10.1038/cgt.2012.21. Epub 2012 May 4.

16.

The timing of neural stem cell-based virotherapy is critical for optimal therapeutic efficacy when applied with radiation and chemotherapy for the treatment of glioblastoma.

Tobias AL, Thaci B, Auffinger B, Rincón E, Balyasnikova IV, Kim CK, Han Y, Zhang L, Aboody KS, Ahmed AU, Lesniak MS.

Stem Cells Transl Med. 2013 Sep;2(9):655-66. doi: 10.5966/sctm.2013-0039. Epub 2013 Aug 7.

17.

Transplantation of human neural stem cells exerts neuroprotection in a rat model of Parkinson's disease.

Yasuhara T, Matsukawa N, Hara K, Yu G, Xu L, Maki M, Kim SU, Borlongan CV.

J Neurosci. 2006 Nov 29;26(48):12497-511.

18.

Migration of human neural stem cells toward an intracranial glioma.

Jeon JY, An JH, Kim SU, Park HG, Lee MA.

Exp Mol Med. 2008 Feb 29;40(1):84-91.

19.

Primary neural stem/progenitor cells expressing endostatin or cytochrome P450 for gene therapy of glioblastoma.

Lorico A, Mercapide J, Solodushko V, Alexeyev M, Fodstad O, Rappa G.

Cancer Gene Ther. 2008 Sep;15(9):605-15. doi: 10.1038/cgt.2008.23. Epub 2008 Apr 18. Erratum in: Cancer Gene Ther. 2009 Jun;16(6):539. Soloduschko, V [corrected to Solodushko, V].

PMID:
18421309
20.

Antitumor effects of genetically engineered stem cells expressing yeast cytosine deaminase in lung cancer brain metastases via their tumor-tropic properties.

Yi BR, Kim SU, Kim YB, Lee HJ, Cho MH, Choi KC.

Oncol Rep. 2012 Jun;27(6):1823-8. doi: 10.3892/or.2012.1721. Epub 2012 Mar 13.

PMID:
22426744

Supplemental Content

Support Center